Signs of Friedreich ataxia (FA) typically appear between the ages of 10 and 15 years, but symptoms can emerge at nearly any age.2 Here are some differences related to age of onset1:
Falls (gait ataxia)
Imbalance (poor proprioception)
Reflex Loss (areflexia)
Sensation Loss (neuropathy)
Tiredness (fatigue)
Cardiomyopathy may be present in younger patients with more severe FA2
Loss of bulbar function may result in patients’ speech sounding slurred and swallowing becoming more difficult2,7
Scoliosis may be an initial indicator of FA when you also see imbalance or other neurological signs2
Patients with LOFA begin experiencing symptoms after 25 years of age and those with VLOFA experience symptoms after 40 years of age. Patients with LOFA and VLOFA may have atypical symptoms:
While there are many scales used to measure progressive neurological decline, the modified Friedreich Ataxia Rating Scale (mFARS) is a clinically validated neurological assessment that provides an evaluation of a patient’s status and is generally accepted as a clinical trial endpoint. As FA progresses, a patient’s mFARS score will worsen (increase).
Tricia, age 44
Diagnosed at age 29
References
1. Rummey C, Corben LA, Delatycki M, et al. Natural history of Friedreich ataxia: heterogeneity of neurologic progression and consequences for clinical trial design. Neurology. 2022;99(14):e1499-e1510. 2. Parkinson MH, Boesch S, Nachbauer W, Mariotti C, Giunti P. Clinical features of Friedreich’s ataxia: classical and atypical phenotypes. J Neurochem. 2013;126(suppl 1):103-117. 3. Donoghue S, Martin A, Larkindale J, Farmer J. A meta-analysis study to evaluate time to diagnosis of Friedreich’s ataxia in the U.S. Friedreich’s Ataxia Research Alliance; 2018. 4. Fogel BL, Perlman S. Clinical features and molecular genetics of autosomal recessive cerebellar ataxias. Lancet Neurol. 2007;6(3):245-257. 5. National Organization of Rare Disorders. Friedreich's ataxia. Revised October 4, 2023. Accessed February 13, 2025. https://rarediseases.org/rare-diseases/friedreichs-ataxia. 6. Schulz JB, Boesch S, Bürk K, et al. Diagnosis and treatment of Friedreich ataxia: a European perspective. Nat Rev Neurol. 2009;5(4):222-234. 7. Rummey C, Corben LA, Delatycki MB, et al. Psychometric properties of the Friedreich Ataxia Rating Scale. Neurol Genet. 2019;5(6):371. 8. Cook A, Giunti P. Friedreich’s ataxia: clinical features, pathogenesis and management. Br Med Bull. 2017;124(1):19-30. 9. Indelicato E, Nachbauer W, Eigentler A, et al; EFACTS (European Friedreich's Ataxia Consortium for Translational Studies). Onset features and time to diagnosis in Friedreich’s ataxia. Orphanet J Rare Dis. 2020;15(1):198. 10. Lynch DR, Farmer JM, Balcer LJ, Wilson RB. Friedreich ataxia: effects of genetic understanding on clinical evaluation and therapy. Arch Neurol. 2002;59(5):743-747. 11. Williams CT, De Jesus O. Friedreich ataxia. National Center for Biotechnology Information Bookshelf. Revised August 23, 2023. Accessed December 15, 2024. https://www.ncbi.nlm.nih.gov/books/NBK563199. 12. Patel M, Isaacs CJ, Seyer L, et al. Progression of Friedreich ataxia: quantitative characterization over 5 years. Ann Clin Transl Neurol. 2016;3(9):684-694.